Physician profile
Alfred Eugene Baylor
NPI 1164490397
$14,188.70
in general payments reported to CMS, 2019-2025
12 companies · $697 in 2025
The $697 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12K · 2022: $1,306 · 2023: $547 · 2024: $35.15 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,259 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.24 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,082.56 | 2021 | |
| Integra Lifesciences Corporation | $1,065.81 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $599.97 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Access Pro Medical, LLC | $414.59 | 2025 | Matriderm |
| Avita Medical Americas, LLC | $385.10 | 2022-2025 | Permeaderm, Recell, Cohealyx |
| Aroa Biosurgery Incorporated | $262.32 | 2022-2023 | |
| Smith+Nephew, INC. | $230.67 | 2021-2023 | Oasis, Versajet, Acticoat 4" X 4" |
| Polynovo North America LLC | $58.90 | 2025 | Novosorb Btm |
| Medline Industries LP | $31.37 | 2023 | |
| Btg International INC. | $21.42 | 2025 | Aurlumyn |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Vericel Corporation | $15.99 | 2025 | Nexobrid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Baylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.